Peptide profile
Calcitonin (Salmon)
Salmon calcitonin for bone density
Compare Calcitonin (Salmon) with other peptides →Summary
Calcium-regulating peptide for bone density & fracture prevention.
- Typical dose
- 100-200 IU Daily
- Route
- Subcutaneous, Nasal
- Cycle length
- Chronic (with monitoring)
- Evidence
- Animal data
Mechanism
How it works
Calcitonin acts like a brake pedal for bone breakdown — it tells osteoclasts to stop dissolving bone, preserving density.
Salmon calcitonin binds to calcitonin receptors on osteoclasts, inhibiting bone resorption and increasing calcium excretion by kidneys.
Reported in research
Benefits
- Increases bone mineral density
- Reduces vertebral fracture risk
- Analgesic effect for bone pain
- Inhibits osteoclast activity
Context, not a prescription
Dosing
- Typical range
- 100-200 IU Daily (Subcutaneous, Nasal)
- Cycle length
- Chronic (with monitoring)
Safety
Side effects & contraindications
Possible side effects
- Nasal irritation (intranasal)
- Nausea
- Headache
- Allergic reaction
- Hypocalcemia
Contraindications
- Hypocalcemia
- Pregnancy or breastfeeding
- Known hypersensitivity
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
Increased bone mineral density, reduced fracture risk, less bone pain.
How it works
Calcitonin acts like a brake pedal for bone breakdown — it tells osteoclasts to stop dissolving bone, preserving density.
Binds to calcitonin receptors on osteoclasts, decreasing their activity and reducing calcium release into blood.
What to expect
Bone effects over months; pain relief within weeks.
- Weeks 2-4: Reduced bone pain.
- Months 3-6: Stabilized bone density.
- Year 1: Increased BMD and reduced fractures.
Good to know
- Monitor calcium levels
- Ensure adequate vitamin D intake
Staying safe
- Nasal irritation (intranasal)
- Nausea
- Headache
Avoid if you have:
- Hypocalcemia
- Pregnancy or breastfeeding
- Known hypersensitivity
Mechanism of action
Salmon calcitonin binds to calcitonin receptors on osteoclasts, inhibiting bone resorption and increasing calcium excretion by kidneys.
Binds to calcitonin receptors on osteoclasts, decreasing their activity and reducing calcium release into blood.
Pharmacodynamics
Bone effects over months; pain relief within weeks.
Increased bone mineral density, reduced fracture risk, less bone pain.
Timeline
- Weeks 2-4: Reduced bone pain.
- Months 3-6: Stabilized bone density.
- Year 1: Increased BMD and reduced fractures.
Comparisons
- Calcitonin — effectiveness Moderate, safety Good, cost $$$, Easy to use
- Bisphosphonates — effectiveness High, safety Good, cost $$, Weekly/Monthly to use
Adverse effects
Common:
- Nasal irritation (intranasal)
- Nausea
- Headache
Rare:
- Allergic reaction
- Hypocalcemia
Contraindications & risk mitigation
Contraindicated in:
- Hypocalcemia
- Pregnancy or breastfeeding
- Known hypersensitivity
- Monitor calcium levels
- Ensure adequate vitamin D intake
Qué hace
Aumento de la densidad mineral ósea, reducción del riesgo de fractura, menor dolor óseo.
Cómo funciona
La calcitonina actúa como un pedal de freno para la descomposición ósea: le indica a los osteoclastos que dejen de disolver el hueso, preservando la densidad.
Se une a los receptores de calcitonina en los osteoclastos, disminuyendo su actividad y reduciendo la liberación de calcio a la sangre.
Qué esperar
Efectos óseos en meses; alivio del dolor en semanas.
- Semanas 2-4: Reducción del dolor óseo.
- Meses 3-6: Densidad ósea estabilizada.
- Año 1: Aumento de la DMO y reducción de fracturas.
Bueno saber
- Monitorear los niveles de calcio
- Asegurar una ingesta adecuada de vitamina D
Manteniéndose seguro
- Irritación nasal (intranasal)
- Náuseas
- Dolor de cabeza
Evitar si tienes:
- Hipocalcemia
- Embarazo o lactancia
- Hipersensibilidad conocida
Mecanismo de acción
La calcitonina de salmón se une a los receptores de calcitonina en los osteoclastos, inhibiendo la resorción ósea y aumentando la excreción de calcio por los riñones.
Se une a los receptores de calcitonina en los osteoclastos, disminuyendo su actividad y reduciendo la liberación de calcio a la sangre.
Farmacodinamia
Efectos óseos en meses; alivio del dolor en semanas.
Aumento de la densidad mineral ósea, reducción del riesgo de fractura, menor dolor óseo.
Cronología
- Semanas 2-4: Reducción del dolor óseo.
- Meses 3-6: Densidad ósea estabilizada.
- Año 1: Aumento de la DMO y reducción de fracturas.
Comparaciones
- Calcitonina — efectividad Moderada, seguridad Buena, costo $$$, Fácil de usar
- Bisfosfonatos — efectividad Alta, seguridad Buena, costo $$, Semanal/Mensual de usar
Efectos adversos
Comunes:
- Irritación nasal (intranasal)
- Náuseas
- Dolor de cabeza
Raros:
- Reacción alérgica
- Hipocalcemia
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Hipocalcemia
- Embarazo o lactancia
- Hipersensibilidad conocida
- Monitorear los niveles de calcio
- Asegurar una ingesta adecuada de vitamina D
Reference data
Specifications
- Route
- Subcutaneous, Nasal
- Cycle length
- Chronic (with monitoring)
FAQ
Common questions
Is salmon calcitonin safe for long-term use?
Yes, but intranasal use has been associated with a slight increased cancer risk in some studies.
Does it build new bone?
Mostly prevents bone loss rather than building new bone; anabolic agents like teriparatide build bone.
What is the evidence level?
This compound is classified as Animal data. Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Research
Research & sources
Current evidence for Calcitonin (Salmon) is rated as Animal data. Research is based primarily on animal models.
- 1. Calcitonin in osteoporosis (2013) — DOI:10.1002/jbmr.1780
- 2. Salmon calcitonin review (2005) — DOI:10.2165/00003495-200565150-00004
- 3. Calcitonin in osteoporosis (2013)
- 4. Salmon calcitonin review (2005)